Sort by
Refine Your Search
-
research team and be supported with career development opportunities such as contributing to academic papers. The RA will be conversant in public health, particularly in relation to mental health, the social
-
(with the possibility of extension) Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development. This entitlement, from the Concordat to Support the Career
-
environment at the Pears Maudsley Centre, with access to extensive neuroimaging, genomic, and clinical datasets and excellent computing infrastructure and expertise in AI. Our career development emphasizes
-
challenges and pressing environmental, geopolitical, urban and rural issues. Our research findings contribute to public debates and policy development at national and international scales, making important
-
, alongside contributing to the development and coordination of the new Race Equity in Care survey. This will include assisting with ethics applications, questionnaire design, and partner liaison
-
Hours per week), and you will be offered a fixed term contract until 30 September 2028 / 2029. Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development
-
currently leading the NeuroHand project—a UKRI-funded programme focused on the development of a soft robotic exoskeleton glove for stroke rehabilitation. The role provides an exciting opportunity
-
are passionate about applying machine learning to real-world clinical challenges. The successful candidate will lead the development and validation of predictive models using multimodal data including neuroimaging
-
. They are currently working on innovative approaches to non-invasive biomarker sampling via the skin, the use of natural compounds to modify skin keratinocyte function, development of topical formulations that generate
-
of neurodevelopmental epilepsy. Identification of common genetic mutations in specific genes has enabled precision diagnosis and more recently the development of genetic therapies. However, we lack the imaging tools